
1. blood cells mol dis. 2015 jun;55(1):30-5. doi: 10.1016/j.bcmd.2015.03.013. epub
2015 mar 31.

plasmodium vivax: n-terminal diversity blood stage sera genes indian 
isolates.

rahul cn(1), shiva krishna k(1), meera m(2), phadke s(3), rajesh v(4).

author information: 
(1)department biological sciences, birla institute technology science, 
pilani, hyderabad campus, andhra pradesh, india.
(2)sir ronald ross institute tropical communicable diseases, hyderabad,
andhra pradesh, india.
(3)ehrlich laboratories, chennai, tamil nadu, india.
(4)department biological sciences, birla institute technology science, 
pilani, hyderabad campus, andhra pradesh, india. electronic address:
vidya_nrajesh@yahoo.com.

worldwide malaria risk due plasmodium vivax makes development vaccine
against p. vivax, high priority. serine repeat antigen p. vivax (pvsera) 
a multigene family blood stage proteins 12 homologues. sequence diversity
studies important understanding potential vaccine candidates. 
information n-terminal diversity genes available literature. in
this paper, evaluate genetic polymorphism n-terminal regions the
highly expressed member pvsera4 pvsera5 genes indian field isolates. our
results show pvsera4 deletions insertions glutamine rich
tetrameric repeat units contributing diversity. pvsera5 also exhibits high
genetic diversity non-synonymous substitutions leading identification 
novel haplotypes india. first report helps elucidating allelic
variants pvsera genes region contributes evaluating their
efficacy vaccine candidates.

copyright Â© 2015 elsevier inc. rights reserved.

doi: 10.1016/j.bcmd.2015.03.013 
pmid: 25976464  [indexed medline]

